Occam Recruits Former FDA Commissioner to Faeth Therapeutics
In November 2024, Occam Global recruited Stephen M. Hahn, M.D., to the board of Faeth Therapeutics. Hahn is a CEO-Partner of Flagship Pioneering and Chief Executive Officer of Harbinger Health.
Steve brings two decades of illustrious leadership in healthcare strategy, oncology, and translational/clinical research to this role. From 2019 to 2021, he served as the 24th U.S. Food and Drug Administration (FDA) Commissioner, overseeing COVID and non-COVID regulatory affairs, including therapeutics and vaccine development, devices, diagnostics, and clinical trials.
Before his appointment to the FDA, Steve held the positions of Chief Medical Executive and Chief Operating Officer at the prestigious MD Anderson Cancer Center in Houston, Texas. Prior to his executive roles at MD Anderson, he also led the Perelman School of Medicine radiation oncology department at the University of Pennsylvania.
Steve earned his M.D. from Temple University and his B.A. in Biology from Rice University.
About Faeth Therapeutics
Faeth Therapeutics focuses on developing cancer treatments by targeting the unique metabolic dependencies of cancer cells. Using insights from computational biology and machine learning, they analyze the specific metabolic pathways that fuel tumor growth. This approach allows Faeth to design therapies that disrupt multiple key metabolic points within cancer cells, aiming to weaken or eliminate their ability to proliferate.
In addition to their scientific innovation, Faeth offers a patient-centric experience through their app, which helps patients adhere to treatment protocols by customizing their nutritional and metabolic support. Their clinical trials incorporate this targeted metabolic approach, providing patients with personalized guidance to maximize the effectiveness of these therapies. This approach represents a shift in oncology by addressing cancer metabolism as a means to improve treatment outcomes.
Explore how we’ve helped life science organizations build exceptional executive leadership through our case studies.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.